Executive Summary
Market Research Methodology
2.1. Research methodology and design
2.2. Sample selection
2.3. Reliability and validity
Market Analysis
3.1. Market size and growth rates
3.2. Macroeconomic change
3.3. Market growth drivers, market dynamics and trends
3.4. Megatrends and their impact
3.5. Value chain analysis
3.6. Distribution platforms
3.7. Market scenarios and opportunity forecasts
3.8. Relevant markets
3.9. The new frontiers of growth
3.10. Creating value through sustainable strategies
Market Breakdown by Product and Services
4.1. Introduction
4.2. Kits & Reagents
4.3. Enzymes
4.4. Instruments & Software
4.5. Services
Market Breakdown by Type
5.1. Introduction
5.2. DNA Methylation
5.3. RNA Methylation
Market Breakdown by Technology
6.1. Introduction
6.2. Microarray
6.3. Polymerase Chain Reaction (PCR
6.4. Sequencing
6.4.1. Whole-Genome Bisulfite Sequencing (WGBS)
6.4.2. Reduced Representation Bisulfite Sequencing (RRBS)
6.4.3. Methyl-CpG-Binding Domain Sequencing (MBD-seq)
6.4.4. Single-molecule real-time (SMRT) sequencing
6.4.5. Nanopore sequencing
6.5. Others
Market Breakdown by Application
7.1. Introduction
7.2. Clinical Research
7.3. Diagnostics
7.4. Gene Therapy
7.5. Others
Market Breakdown by End-Use
8.1. Introduction
8.2. Pharmaceutical and Biotechnology Companies
8.3. Hospitals and Diagnostic Laboratories
8.4. Research and Academia
Market Breakdown by Geography
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Russia
9.3.5. Italy
9.3.6. Spain
9.3.7. Sweden
9.3.8. Belgium
9.3.9. Denmark
9.3.10. Austria
9.3.11. Switzerland
9.3.12. Netherlands
9.3.13. Others
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.4.4. India
9.4.5. Australia
9.4.6. Others
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Israel
9.5.5. Others
Competitive Landscape
10.1. Competitive situation and trends
10.2. Industry benchmarking
10.3. Expansion path
10.4. Recent market and industry developments
10.4.1. New product developments and announcements
10.4.2. Agreements, partnerships, joint ventures, and collaborations
10.4.3. Mergers and acquisitions and major PE deals
Companies Profiled
11.1. Abcam plc
11.2. Agilent Technologies Inc.
11.3. Bio-Rad Laboratories, Inc.
11.4. Diagenode Diagnostics S.A.
11.5. Exact Sciences Corporation
11.6. F. Hoffmann-La Roche Ltd
11.7. Illumina Inc.
11.8. New England Biolabs
11.9. QIAGEN
11.10. Thermo Fisher Scientific Inc.